findmyKOL
Clinical trialNCT05645744TerminatedObservational

Long-term Follow-up Study in Patients Previously Treated With a Mustang Bio CAR-T Cell Investigational Product.

SponsorMustang BioEnrollment3B-cell Lymphoma RefractoryBlastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)Chronic Lymphocytic Leukemia in RelapseDiffuse Large B Cell LymphomaFollicular B-cell Non-Hodgkin's LymphomaHairy Cell Leukemia+5 more conditions
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

A long-term follow-up study to assess safety and efficacy in patients previously treated with Mustang Bio chimeric antigen receptor (CAR)-T cell investigational products.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Uc Irvine Health - Chao Family Comprehensive Cancer Center

    Orange, California, United States

  • Massachusetts General Hospital

    Boston, Massachusetts, United States

  • University of Rochester Medical Center

    Rochester, New York, United States

  • Cleveland Clinic

    Cleveland, Ohio, United States

  • Fred Hutchinson Cancer Center

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Prior MB-102 CAR-T cell investigational productPrior MB-106 CAR-T cell investigational product
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
29 Sept 2021
Primary completion
12 Apr 2024
Completion
12 Apr 2024
Last update posted
22 Jul 2024
Registered enrollment
3
Registry id
NCT05645744

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.